Cargando…

Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022

We studied SARS-CoV-2 genomes from travelers arriving in Hong Kong during November 2021–February 2022. In addition to Omicron and Delta variants, we detected a BA.1/BA.2 recombinant with a breakpoint near the 5′ end of the spike gene in 2 epidemiologically linked case-patients. Continued surveillanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Haogao, Ng, Daisy Y.M., Liu, Gigi Y.Z., Cheng, Samuel S.M., Krishnan, Pavithra, Chang, Lydia D.J., Cheuk, Sammi S.Y., Hui, Mani M.Y., Lam, Tommy T.Y., Peiris, Malik, Poon, Leo L.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155883/ https://www.ncbi.nlm.nih.gov/pubmed/35394420 http://dx.doi.org/10.3201/eid2806.220523

Ejemplares similares

Monitoring International Travelers Arriving in Hong Kong for Genomic Surveillance of SARS-CoV-2
por: Gu, Haogao, et al.
Publicado: (2022)

Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong
por: Gu, Haogao, et al.
Publicado: (2021)

SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021
por: Chu, Daniel K.W., et al.
Publicado: (2021)

SARS-CoV-2 under an elimination strategy in Hong Kong
por: Gu, Haogao, et al.
Publicado: (2021)

Within-host diversity of SARS-CoV-2 lineages and effect of vaccination
por: Gu, Haogao, et al.
Publicado: (2022)

Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021
por: Gu, Haogao, et al.
Publicado: (2022)

Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong
por: Xie, Ruopeng, et al.
Publicado: (2023)

Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China
por: Chu, Daniel K.W., et al.
Publicado: (2021)

Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong
por: Gu, Haogao, et al.
Publicado: (2022)

Risk of within-hotel transmission of SARS-CoV-2 during on-arrival quarantine in Hong Kong: an epidemiological and phylogenomic investigation
por: Adam, Dillon C., et al.
Publicado: (2023)

Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters
por: Su, Wen, et al.
Publicado: (2022)

Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals
por: Gu, Haogao, et al.
Publicado: (2023)

Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
por: Hui, Kenrie P.Y., et al.
Publicado: (2022)

Air travel-related outbreak of multiple SARS-CoV-2 variants
por: Dhanasekaran, Vijaykrishna, et al.
Publicado: (2021)

Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January–March 2022
por: Mefsin, Yonatan M., et al.
Publicado: (2022)

Estimating the serial intervals of SARS‐CoV‐2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong
por: Guo, Zihao, et al.
Publicado: (2023)

Development of multiplex RT‐ddPCR assays for detection of SARS‐CoV‐2 and other common respiratory virus infections
por: Leong, Nathaniel K. C., et al.
Publicado: (2022)

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
por: Hachmann, Nicole P., et al.
Publicado: (2022)

Repolarization of Ferroelectric Superlattices BaZrO(3)/BaTiO(3)
por: Sidorkin, A. S., et al.
Publicado: (2019)

Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection
por: Cheng, Samuel SM, et al.
Publicado: (2022)

Identification of the neutron-rich nuclides /sup 147; 148/Ba and half- life determination of the heavy isotopes of Rb, Sr, Y, Cs, Ba and La
por: Amiel, S, et al.
Publicado: (1976)

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
por: Tseng, Hung Fu, et al.
Publicado: (2023)

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
por: Wang, Qian, et al.
Publicado: (2022)

Asymmetrical Dependence of {Ba(2+)}:{SO(4)(2–)} on BaSO(4) Crystal Nucleation and Growth in Aqueous Solutions: A Dynamic Light Scattering Study
por: Seepma, Sergěj Y. M. H., et al.
Publicado: (2023)

To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)

Impact of Solution {Ba(2+)}:{SO(4)(2–)} on Charge Evolution of Forming and Growing Barite (BaSO(4)) Crystals: A ζ—Potential Measurement Investigation
por: Seepma, Sergěj Y. M. H., et al.
Publicado: (2023)

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021–February 2022
por: Sofonea, Mircea T., et al.
Publicado: (2022)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
por: Emmelot, Maarten E., et al.
Publicado: (2022)

Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
por: Lewnard, Joseph A., et al.
Publicado: (2023)

Diagonal nematicity in the pseudogap phase of HgBa(2)CuO(4+δ)
por: Murayama, H., et al.
Publicado: (2019)

Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5
por: Tartof, Sara Y, et al.
Publicado: (2022)

Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England
por: Abdul Aziz, Nurin, et al.
Publicado: (2023)

Polar metal phase stabilized in strained La-doped BaTiO(3)films
por: Takahashi, K. S., et al.
Publicado: (2017)

Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
por: Bowen, John E., et al.
Publicado: (2022)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
por: Muik, Alexander, et al.
Publicado: (2022)

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
por: Zhong, NS, et al.
Publicado: (2003)

Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
por: Arora, Prerna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kujgnrbonsud35l8dfj08q85a8